NEW YORK, Nov. 7 — San Diego-based GeneFormatics on Wednesday said that it has added Edward Lanphier to its board of directors.

Lanphier, the founder, president and CEO of Sangamo BioSciences, will assist the privately-held structural proteomics firm with business development and management. 

Lanphier founded Sangamo BioSciences in 1997. Before that he was a senior executive at Somatix Therapy Corporation, vice president for corporate development at Synergen, and the former president and CEO of BioGrowth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.